
P53R3
CAS No. 922150-12-7
P53R3( —— )
Catalog No. M16608 CAS No. 922150-12-7
P53R3 is a novel p53 reactivator that restores sequence-specific DNA binding of the endogenously expressed p53(R175H) and p53(R273H) mutants in gel-shift assays.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 260 | Get Quote |
![]() ![]() |
10MG | 390 | Get Quote |
![]() ![]() |
25MG | 645 | Get Quote |
![]() ![]() |
50MG | 888 | Get Quote |
![]() ![]() |
100MG | 1233 | Get Quote |
![]() ![]() |
500MG | 2457 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameP53R3
-
NoteResearch use only, not for human use.
-
Brief DescriptionP53R3 is a novel p53 reactivator that restores sequence-specific DNA binding of the endogenously expressed p53(R175H) and p53(R273H) mutants in gel-shift assays.
-
DescriptionP53R3 is a novel p53 reactivator that restores sequence-specific DNA binding of the endogenously expressed p53(R175H) and p53(R273H) mutants in gel-shift assays; induces p53-dependent antiproliferative effects with much higher specificity and over a wider range of concentrations than PRIMA-1; strongly enhances the mRNA, total protein and cell surface expression of DR5.
-
In VitroP53R3 (10?μg/ml; 24 hours; in the absence or presence of the unlabelled p53 consensus oligonucleotide) restores p53-specific DNA binding activity to p53R273H (a DNA contact mutant) and p53R175H (a structural mutant) in WiDr colon tumour cells harbouring p53R273H?and KLE cells with p53R175H.P53R3 (1-33 μg/ml; 24 hours) inhibits the proliferation of the LN-308 sublines expressing mutant p53 plasmids in a p53-dependent manner. The p53R175H-dependent effects are strong over a broad range of concentrations, but p53R273H-dependent effects are weaker and requires high concentrations of P53R3.P53R3 induces p53R248W?reactivation is more pronounced proliferation inhibition than observed with p53R273H. P53R3 does not exhibit cytotoxic effects even at concentrations close to its solubility limit (33?μg/ml).P53R3 (33?μg/ml; 18 hours) induces a strong decrease in S phase cells and a G0/G1?cell cycle arrest in LN-308 p53R175H?and LN-308 p53R273H cells. But it does not affect cell cycle distribution of LN-308 p53R248W?cells. Cell Viability AssayCell Line:p53 null LN-308 human glioma cells with a control plasmid or plasmids encoding the mutants p53R175H, p53R248W?and p53R273H Concentration:1-33 μg/mL Incubation Time:24 hours Result:Induced p53-dependent and -independent antiproliferative and cytotoxic effects in vitro.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetMDM2-p53
-
RecptorMDM2-p53
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number922150-12-7
-
Formula Weight592.565
-
Molecular FormulaC32H35Cl2N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (168.76 mM)
-
SMILES——
-
Chemical Namemethyl (2-((4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)methyl)quinazolin-4-yl)-L-valinate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Weinmann L, et al. Cell Death Differ. 2008 Apr;15(4):718-29.
molnova catalog



related products
-
AMG 232
AMG 232 is a potent, selective, orally bioavailable MDM2-p53 inhibitor with Kd of 0.045 nM.
-
HDM-201
HDM-201 (NVP-HDM 201, Siremadlin)?is a highly potent p53-MDM2 interaction inhibitor with biochemical IC50 of 0.13 nM, cellular IC50 of 90 nM.
-
Nutlin-3
Nutlin-3 is MDM2 antagonist. Nutlin-3 inhibits the MDM2-p53 interaction (IC50 = 0.09 μM) and activates p53.